Xinling Xu

Papers

1

Total Citations

17

H-Index

1

About

Xinling Xu is a clinical researcher whose work bridges anesthesiology, perioperative medicine, and surgical outcomes, with a focus on improving patient recovery and pain management after major urologic procedures. Her most cited study, a prospective, randomized, double-blind, placebo-controlled trial published in 2018, evaluated the impact of intravenous acetaminophen versus placebo in patients undergoing robotic-assisted laparoscopic prostatectomy (RALP). This work, with 17 citations, addresses a critical gap in perioperative care for one of the most common surgeries in men—radical prostatectomy for prostate cancer. By rigorously testing a simple, non-opioid analgesic intervention, Xu’s research contributes to evidence-based strategies for reducing opioid use and enhancing recovery after surgery. Her findings help inform clinical protocols that prioritize patient comfort while minimizing side effects, aligning with broader efforts in enhanced recovery after surgery (ERAS) pathways. Xu’s work demonstrates a commitment to high-quality, patient-centered research that directly impacts surgical practice and postoperative outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Intravenous Acetaminophen Versus Placebo in Patients Undergoing Robotic-Assisted Laparoscopic Prostatectomy
17 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 6

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago